Alison Long
Fortuna: 746 535 $ al 31/05/2026
Fortuna: 746 535 $ al 31/05/2026
Dr. Alison Long is an Independent Director at Taysha Gene Therapies, Inc. and a Chief Medical Officer at Flightpath Biosciences, Inc. She is on the Board of Directors at Taysha Gene Therapies, Inc. Dr. Long was previously employed as a Chief Medical Officer by Anokion SA, a Chief Medical Officer by Kaleido Biosciences, Inc., a Chief Medical Officer by Freeline Therapeutics Holdings Ltd., and a Head-Clinical R&D by Spark Therapeutics, Inc. She received her undergraduate degree from the University of the Witwatersrand and a doctorate degree from George Mason University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/06/2026 | 127.178 ( 0,05 % ) | 746 535 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Director/Miembro de la Junta | 01/11/2023 |
Flightpath Biosciences, Inc.
Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Director Técnico/Científico/I+D | 01/01/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Director Técnico/Científico/I+D | 01/01/2023 |
| KALEIDO BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 01/04/2022 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Director Técnico/Científico/I+D | 01/11/2021 |
| SPARK THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/06/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
George Mason University
George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Witwatersrand
University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Flightpath Biosciences, Inc.
Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Freeline Therapeutics Holdings Plc
Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.